Background During the COVID-19 pandemic, the provision of and access to health care
have been uniquely challenging, particularly during lockdowns or when dealing with COVID …

Background Guideline-directed medical therapy (GDMT) remains underutilized in patients
with heart failure with reduced ejection fraction, leading to morbidity and mortality …

Heart failure (HF) is responsible for substantial morbidity among the estimated 6 million
affected adults in the United States. 1 For HF with reduced ejection fraction (HFrEF), optimal …

Heart failure is a chronic condition that affects millions of people worldwide and is
associated with high morbidity and mortality. Remote monitoring, which includes the use of …

Background Chronic heart failure (HF) is a chronic disease affecting more than 64 million
people worldwide, with an increasing prevalence and a high burden on individual patients …

Background: Responding to the need to investigate potential treatments of COVID-19, a
research team employed a telehealth platform to determine whether niclosamide, an oral …

Background: Globally heart failure is a leading cause of morbidity and mortality. This chronic
disease causes severe symptoms with a significant burden to society and health care …

Background Chronic diseases impose a substantial burden on society, and enhancing the
quality of chronic disease management in primary care settings has emerged as a policy …